China Life Chengtuo reduces stake in Bloomage Biotechnology

Bloomage Biotechnology Corporation announced that its major shareholder, China Life Chengtuo (Shanghai) Health Industry Equity Investment Center (Limited Partnership), decreased its stake in the company. On November 26, 2025, China Life Chengtuo sold 571,782 shares through centralized bidding.

Following this transaction, China Life Chengtuo's shareholding decreased from 28,936,504 shares to 28,364,722 shares. This reduction caused their total stake to fall from 6.01% to 5.89% of the company's total share capital, crossing the 1% integer threshold. This move is part of a previously disclosed share reduction plan.

The company confirmed that this equity change is a proactive reduction by the shareholder and does not involve a tender offer. It will not alter the company's actual control, governance structure, or ongoing operations. Furthermore, the transaction complies with relevant securities laws and regulations.